잠시만 기다려 주세요. 로딩중입니다.

2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction

Korean Circulation Journal 2020년 50권 10호 p.845 ~ 866
김현국, 안영근, 장기육, 정영훈, 한주용, 추은호, 김민철, 김효수, 김원, 김원, 조명찬, 장양수, 김종진, 정명호, 채성철,
소속 상세정보
김현국 ( Kim Hyun-Kuk ) - Chosun University College of Medicine Department of Internal Medicine
안영근 ( Ahn Young-Keun ) - Chonnam National University Hospital Department of Cardiology
장기육 ( Chang Ki-Yuk ) - Catholic University Seoul St. Mary’s Hospital Division of Cardiology
정영훈 ( Jeong Young-Hoon ) - Gyeongsang National University Changwon Hospital Department of Internal Medicine
한주용 ( Hahn Joo-Yong ) - Sungkyunkwan University School of Medicine Samsung Medical Center Heart Vascular and Stroke Institute
추은호 ( Choo Eun-Ho ) - Catholic University Seoul St. Mary’s Hospital Division of Cardiology
김민철 ( Kim Min-Chul ) - Chonnam National University Hospital Department of Cardiology
김효수 ( Kim Hyo-Soo ) - Seoul National University Hospital Department of Internal Medicine
김원 ( Kim Weon ) - Kyung Hee University Hospital Department of Internal Medicine
김원 ( Kim Weon ) - Kyung Hee University Hospital Department of Internal Medicine
조명찬 ( Cho Myeong-Chan ) - Chungbuk National University College of Medicine Department of Internal Medicine
장양수 ( Jang Yang-Soo ) - Yonsei University College of Medicine Division of Cardiology
김종진 ( Kim Chong-Jin ) - Kyung Hee University Hospital at Gangdong Cardiovascular Center
정명호 ( Jeong Myung-Ho ) - Chonnam National University Hospital Department of Cardiology
채성철 ( Chae Shung-Chull ) - Kyungpook National University Hospital Department of Internal Medicine

Abstract


Clinical practice guidelines published by the European Society of Cardiology and the American College of Cardiology/American Heart Association summarize the available evidence and provide recommendations for health professionals to enable appropriate clinical decisions and improve clinical outcomes for patients with acute myocardial infarction (AMI). However, most current guidelines are based on studies in non-Asian populations in the pre-percutaneous coronary intervention (PCI) era. The Korea Acute Myocardial Infarction Registry is the first nationwide registry to document many aspects of AMI from baseline characteristics to treatment strategies. There are well-organized ongoing and published randomized control trials especially for antiplatelet therapy among Korean patients with AMI. Here, members of the Task Force of the Korean Society of Myocardial Infarction review recent published studies during the current PCI era, and have summarized the expert consensus for the pharmacotherapy of AMI.

키워드

Myocardial infarction; Drug therapy

원문 및 링크아웃 정보

 

등재저널 정보

SCI(E)
KCI
KoreaMed
KAMS